Matinas BioPharma Holdings logo
Matinas BioPharma Holdings MTNB
$ 0.61 0.0%

Quarterly report 2025-Q3
added 11-10-2025

report update icon

Matinas BioPharma Holdings Long Term Debt Current 2011-2026 | MTNB

Annual Long Term Debt Current Matinas BioPharma Holdings

2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
761 K 656 K 562 K 539 K 391 K 424 K - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
761 K 391 K 556 K

Long Term Debt Current of other stocks in the Biotechnology industry

Issuer Long Term Debt Current Price % 24h Market Cap Country
MorphoSys AG MorphoSys AG
MOR
3.63 M - 2.43 % $ 254 M germanyGermany
AbCellera Biologics AbCellera Biologics
ABCL
5.82 M $ 3.56 - $ 1.06 B canadaCanada
Acorda Therapeutics Acorda Therapeutics
ACOR
1.59 M - -24.86 % $ 820 K usaUSA
Acasti Pharma Acasti Pharma
ACST
75 K - 4.01 % $ 150 M canadaCanada
Advaxis Advaxis
ADXS
166 K - -9.65 % $ 45.9 M usaUSA
AC Immune SA AC Immune SA
ACIU
1.03 M $ 3.13 - $ 229 M schweizSchweiz
I-Mab I-Mab
IMAB
8.06 M - - $ 866 M chinaChina
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
625 K - - $ 1.01 B usaUSA
AgeX Therapeutics AgeX Therapeutics
AGE
428 K - -10.17 % $ 12.2 K usaUSA
Albireo Pharma Albireo Pharma
ALBO
3.08 M - -0.23 % $ 916 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
48 K - 10.36 % $ 9.8 M usaUSA
ADC Therapeutics SA ADC Therapeutics SA
ADCT
1.1 M $ 4.22 - $ 105 M schweizSchweiz
Aptorum Group Limited Aptorum Group Limited
APM
433 K $ 0.79 0.01 % $ 4.31 M chinaChina
argenx SE argenx SE
ARGX
6.53 M $ 703.3 - $ 25 B niderlandNiderland
Adverum Biotechnologies Adverum Biotechnologies
ADVM
5.67 M - - $ 86.2 M usaUSA
Ascendis Pharma A/S Ascendis Pharma A/S
ASND
14.2 M $ 231.03 2.23 % $ 5 B danmarkDanmark
Alterity Therapeutics Limited Alterity Therapeutics Limited
ATHE
57.6 K $ 3.61 - $ 8.69 B australiaAustralia
Atea Pharmaceuticals Atea Pharmaceuticals
AVIR
843 K $ 6.05 - $ 493 M usaUSA
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
1.27 M - - $ 26.5 M usaUSA
Applied Molecular Transport Applied Molecular Transport
AMTI
4.64 M - - $ 10.1 M usaUSA
Arcturus Therapeutics Holdings Arcturus Therapeutics Holdings
ARCT
4.21 M $ 6.63 - $ 182 M israelIsrael
BioCardia BioCardia
BCDA
333 K $ 1.27 - $ 26.9 M usaUSA
Athersys Athersys
ATHX
1.01 M - 3.77 % $ 22.4 M usaUSA
Akouos Akouos
AKUS
671 K - 0.23 % $ 488 M usaUSA
Acer Therapeutics Acer Therapeutics
ACER
104 K - 2.71 % $ 14 M usaUSA
ARCA biopharma ARCA biopharma
ABIO
213 K - 1052.0 % $ 415 M usaUSA
Allena Pharmaceuticals Allena Pharmaceuticals
ALNA
317 K - 3.16 % $ 1.9 M usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
271 K - 5.93 % $ 314 M canadaCanada
AlloVir AlloVir
ALVR
10.8 M - 4.14 % $ 49.1 M usaUSA
Catalyst Biosciences Catalyst Biosciences
CBIO
636 K $ 11.58 - $ 1.03 B usaUSA
Cerus Corporation Cerus Corporation
CERS
2.9 M $ 1.8 6.51 % $ 343 M usaUSA
Anika Therapeutics Anika Therapeutics
ANIK
1.6 M $ 14.36 - $ 210 M usaUSA
Aptinyx Aptinyx
APTX
337 K - -39.0 % $ 4.57 M usaUSA
BioNTech SE BioNTech SE
BNTX
45 M $ 90.54 - $ 27.2 B germanyGermany
Aptose Biosciences Aptose Biosciences
APTO
428 K - -45.71 % $ 1.2 M canadaCanada
AVEO Pharmaceuticals AVEO Pharmaceuticals
AVEO
11 K - - $ 521 M usaUSA
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
419 K - - $ 7.46 M israelIsrael
Aytu BioScience Aytu BioScience
AYTU
137 K $ 2.64 - $ 16.6 M usaUSA
Cardiff Oncology Cardiff Oncology
CRDF
730 K $ 1.9 - $ 127 M usaUSA
CorMedix CorMedix
CRMD
853 K $ 6.54 - $ 471 K usaUSA
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
5.05 M $ 1.51 - $ 385 M britainBritain